Loading clinical trials...

RECRUITINGNA

Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes

NCT07085754•Yuhui Qiu

Summary

This study aims to investigate the effects of 24-hour acute sleep deprivation on plasma Alzheimer's disease biomarkers and multi-omics in individuals with different APOE genotypes, to elucidate the potential role of acute sleep deprivation in AD risk.

Detailed Description

This is a randomized controlled trial designed to enroll 60 healthy volunteers. Stratified randomization will be used, with three strata defined by APOE genotype (APOE ε3/3, APOE ε4 carriers, and APOE ε2 carriers) in a 1:1:1 ratio. Within each stratum, participants will be randomly assigned in a 1:1 ratio to either the acute sleep-deprivation group or the non-acute sleep-deprivation group. The intervention will consist of 24 hours of acute sleep deprivation. The primary outcome measure is the change from baseline in plasma Aβ42 on the first day after randomization.

Eligibility

Age

18 - 40 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18-40 years, gender not limited
•Healthy (with no clinically significant abnormal findings in the physical examination report or self-reporting as healthy) and not on medications
•Cognitively normal (Mini-Mental State Examination (MMSE) score \> 28)
•Sleep duration of 7-9 hours per night, good sleep quality (Pittsburgh Sleep Quality Index (PSQI) ≤ 5 points)
•Written informed consent, voluntarily participate in this study, and be able to cooperate with the physician to complete the clinical study

Exclusion Criteria

•Presence of day-night sleep reversal
•Shift work within the past 6 months
•Travel across time zones or experience of jet lag within the past three weeks
•Current smoking or nicotine use; alcohol consumption exceeding five standard units per week (one standard alcohol unit is defined as 10 mL \[or 8 g\] of pure alcohol)
•Consumption of strong tea, coffee, or caffeine-containing foods and beverages within one week before study participation
•Family history of early-onset dementia
•Self-Rating Depression Scale (SDS) score ≥ 53, Self-Rating Anxiety Scale (SAS) score ≥ 50
•Female participants who are currently pregnant or breastfeeding
•Individuals who need to drive or operate vehicles or machinery during the study period

Locations (1)

Guangdong Provincial Hospital of Chinese Medicine

Guangzhou, Guangdong, China

Key Dates

Start Date

August 8, 2025

Primary Completion Date

December 31, 2025

Completion Date

December 31, 2026

Last Updated

December 24, 2025

Enrollment

ESTIMATED participants

Conditions

SleepSleep Deprivation

Interventions

Sleep Deprivation

BEHAVIORAL

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957

Obstructive Sleep Apnea Risk ManagementPostoperative Complications+2 more

View study

RECRUITING

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

NCT01778504

Neuropsychiatric DisorderNeurological Disorder+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes

Inclusion Criteria

Exclusion Criteria

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

Light Exposure, Migraine Outcomes, and Sleep Quality

MyVitalC: Sleep and Everyday Headache Management

Digital-supported Orofacial Myofunctional Therapy in OSA

Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder